RT-PCR (Reverse Transcription Polymerase Chain Reaction) is a laboratory technique used to detect and measure RNA (ribonucleic acid) in a biological sample. It is a sensitive and specific method for detecting the presence of RNA from a specific virus, such as SARS-CoV-2, the virus that causes COVID-19. During an RT-PCR test, a healthcare professional collects a sample from the nose or throat of the patient using a swab. The sample is then processed in a laboratory, where RNA is extracted and converted to DNA (deoxyribonucleic acid) using an enzyme called reverse transcriptase.
n a person's blood. Antibodies are proteins produced by the immune system in response to an infection or vaccine. Antibody tests are used to determine if a person has been exposed to a specific virus, such as SARS-CoV-2, the virus that causes COVID-19. During an antibody test, a healthcare professional collects a sample of the patient's blood, which is then analyzed in a laboratory. The test looks for the presence of antibodies specific to the virus in question. If antibodies are present, it indicates that the person has been infected with the virus at some point in the past and has developed an immune response to the infection.
A rapid antigen test is a diagnostic test that is used to detect the presence of specific viral proteins, called antigens, in a sample of bodily fluid (such as saliva, nasal swab, or throat swab). These tests are designed to quickly identify individuals who are currently infected with a particular virus, such as SARS-CoV-2 (the virus that causes COVID-19). Rapid antigen tests can be performed at the point of care, meaning that they can be administered and processed in a doctor's office, clinic, or other healthcare setting, without the need for specialized laboratory equipment or extensive processing time.